Eisai
Lynn Ehrlich serves as the Executive Director of Commercial Planning & Operations at Eisai US since August 2016, having previously held the role of Sr Director Commercial Effectiveness. Prior experience includes significant positions at Otsuka Pharmaceutical Companies (U.S.) such as Director of Neuroscience Operations and National Director of Strategic Sales Alliances. Lynn has demonstrated expertise in Commercial Operations and Sales Leadership within both injectable and tablet markets, focusing on sales force effectiveness, training, operations, and customer support. Earlier career achievements at Novo Nordisk A/S and Novartis highlight a solid track record in sales strategy, team leadership, and operational excellence, complemented by a BA in Communications and Business Communications from the College of Charleston.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.